Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia E Neumann

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
ACS Nano|March 8, 2025
Extracellular Vesicles Carrying Tenascin-C are Clinical Biomarkers and Improve Tumor-Derived DNA Analysis in Glioblastoma PatientsAmanda Salviano-Silva, Kathrin Wollmann, Santra Brenna, et al.
Acta Neuropathologica|January 20, 2024
Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastomaRichard Drexler, Robin Khatri, Ulrich Schüller, et al.
Neuropathology and Applied Neurobiology|February 13, 2022
Low-grade diffusely infiltrative tumour (LGDIT), SMARCB1-mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT-MYCMartin Hasselblatt, Christian Thomas, Aniello Federico, et al.
Nature Medicine|September 12, 2017
A mouse model for embryonal tumors with multilayered rosettes uncovers the therapeutic potential of Sonic-hedgehog inhibitorsJulia E Neumann, Annika K Wefers, Sander Lambo, et al.
Nature Communications|July 23, 2024
Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan levelShweta Godbole, Hannah Voß, Antonia Gocke, et al.
Neuro-Oncology|April 5, 2022
Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing diseaseMichael Bockmayr, Kim Harnisch, Lara C Pohl, et al.
Nature Communications|November 24, 2023
Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signaturesMelanie Schoof, Shweta Godbole, Thomas K Albert, et al.
Developmental Cell|March 20, 2018
Opposing Effects of CREBBP Mutations Govern the Phenotype of Rubinstein-Taybi Syndrome and Adult SHH MedulloblastomaDaniel J Merk, Jasmin Ohli, Natalie D Merk, et al.
Acta Neuropathologica|June 11, 2025
Outcome-associated factors in a molecularly defined cohort of central neurocytomaMaja Krech, Amos Muench, Daniel Teichmann, et al.
Acta Neuropathologica|July 9, 2024
Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseasesFeizhi Song, Valerija Kovac, Behnam Mohammadi, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
ACS Nano|March 8, 2025
Extracellular Vesicles Carrying Tenascin-C are Clinical Biomarkers and Improve Tumor-Derived DNA Analysis in Glioblastoma PatientsAmanda Salviano-Silva, Kathrin Wollmann, Santra Brenna, et al.
Acta Neuropathologica|January 20, 2024
Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastomaRichard Drexler, Robin Khatri, Ulrich Schüller, et al.
Neuropathology and Applied Neurobiology|February 13, 2022
Low-grade diffusely infiltrative tumour (LGDIT), SMARCB1-mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT-MYCMartin Hasselblatt, Christian Thomas, Aniello Federico, et al.
Nature Medicine|September 12, 2017
A mouse model for embryonal tumors with multilayered rosettes uncovers the therapeutic potential of Sonic-hedgehog inhibitorsJulia E Neumann, Annika K Wefers, Sander Lambo, et al.
Nature Communications|July 23, 2024
Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan levelShweta Godbole, Hannah Voß, Antonia Gocke, et al.
Neuro-Oncology|April 5, 2022
Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing diseaseMichael Bockmayr, Kim Harnisch, Lara C Pohl, et al.
Nature Communications|November 24, 2023
Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signaturesMelanie Schoof, Shweta Godbole, Thomas K Albert, et al.
Developmental Cell|March 20, 2018
Opposing Effects of CREBBP Mutations Govern the Phenotype of Rubinstein-Taybi Syndrome and Adult SHH MedulloblastomaDaniel J Merk, Jasmin Ohli, Natalie D Merk, et al.
Acta Neuropathologica|June 11, 2025
Outcome-associated factors in a molecularly defined cohort of central neurocytomaMaja Krech, Amos Muench, Daniel Teichmann, et al.
Acta Neuropathologica|July 9, 2024
Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseasesFeizhi Song, Valerija Kovac, Behnam Mohammadi, et al.
Pageof 5